期刊文献+

精神分裂症患者与过氧化氢酶(Catalase)基因多态性

The Association between Schizophrenics and Catalase Gene Polymorphism
下载PDF
导出
摘要 目的:探讨过氧化氢酶(Catalase)基因多态性与精神分裂症的相关性。方法:采用Amp-RFLP(amplication-restriction freg-ment lengh polymorphis)方法对精神分裂症患者和对照组的过氧化氢酶基因相关性进行了研究。结果:167例精神分裂症患者与155例对照组之间过氧化氢酶基因型频率和等位基因频率无统计学意义,76例女性精神分裂症患者与60例对照组之间过氧化氢酶基因型频率(x^2=11.096,df=2,P=0.004)有显著性差异。结论:过氧化氢酶多态性与精神分裂症的遗传学并不存在关联性,但是研究表明过氧化氢酶基因型频率与女性精神分裂症患者有显著性差异。 Objective :To explore the association between schizophrenics and catalase gene polymorphism. There is increasing evidence that free radial - mediated CNS neuronal dysfunction is involved in the pathophysiology of schizophrenia. This study was performed to examine the relationship between antioxidant defense system and schizophrenia by analyzing polymorphism of catalase gene, an antioxidant enzyme. Methods:Genotype and allele frequencies in the promoter region in the catalase gene using restriction fragment length polymorphism were studied, comparing 155 controls with 167 schizophrenics. Results: No difference was found between the schizophrenics and the controls in genotype and allele frequencies of Hinfl polymorphism in the catalase gene. Significant difference was found between the female schizophrenics and the female controls in the genotype distribution ( x^2 = 11. 096, df = 2, P = 0. 004 ). Conclusions: The results do not support an association between polymorphism of eatalase gene and schizophrenia. However, this study suggests that Hinfl polymorphism in the catalase gene could be associated with female schizophrenics.
出处 《中国民康医学》 2009年第13期1484-1487,共4页 Medical Journal of Chinese People’s Health
基金 基金项目:韩国庆熙大学高黄医学研究基金项目资助(01-PJ8-PG6-01NE01-0004).
关键词 精神分裂症 过氧化氢酶(Catalase) 基因多态性 Schizophrenia Free radical Catalase Polymorphism Association
  • 相关文献

参考文献17

  • 1杨建中,司天梅,凌炎苏,阮燕,韩永华,王希林,周沫,张鸿燕,孔庆梅,李雪倪,刘萃,张大荣,舒良,张岱.肿瘤坏死因子α基因(TNFα)-G308A多态性与精神分裂症的关联[J].中国心理卫生杂志,2003,17(6):415-417. 被引量:12
  • 2陈毅昌,陈家强,张良诚,陈志锐,蔡教壁,黄少娟,陈维基,郭锦滔,古国谋,伍新尧.5-羟色胺2A受体基因多态性与精神分裂症的相关性研究[J].中国神经精神疾病杂志,1998,24(6):336-338. 被引量:12
  • 3Mahadik SP, Mukherjee. Free radical pathology and antioxidant defense in schizhophrenia: a review. Schizophr Res, 1996,19 : 1 -17.
  • 4Mukherjee S, Mahadik SP, Horrobin DF, et al. Membrane fatty acid composition of fibroblasts from schizophrenic patients[J]. Biol Psychiatry, 1994,35:700.
  • 5Bielski BHJ, Arudi RL, Sutherland. A study of the reactivity of HO2- O2? -with unsaturated fatty acids [J]. J Biol Chem, 1983,258:4759 - 4761.
  • 6Horrobin DF, Manku MS, Hillman S, et al. Fatty acid levels in brains of schizophrenics and normal controls[J]. Biol psychiatry, 1991,30:795 - 805.
  • 7Herken H, Uz E, Ozyurt H, et al. Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in defferent from of schizophrenia [ J ]. Mol Psychiatry,2001,6:66 - 73.
  • 8Reddy R, Mahadik SP, Mukherjee S, et al. Enzymes of the antioxidant defense system in chronic schizophrenic patients [ J ]. Biol Psychiatry, 1991,30:409 - 412.
  • 9Abdalla DSP, Manteiro HP, Olivera JAC, et al. Activities of superoxide dismutase and glutathione peroxidase in schizophrenic and manic depressive patients[J]. Clin Chem, 1986,32:805 - 807.
  • 10Mukherjee S, Scheffer R, Correnti EE, et al. Ealy relapse after recovery from a first episode of psychosis: possible role of oxidative stress [ J ]. Schizophr Res, 1995,15 : 159 - 160.

二级参考文献27

  • 1Kendler KS. The genetics of schizophrenia : an overview. In: Tsuang MT, Simpson JC (Eds) .Handbook of Schizophrenia, Volume 3, Nosology, Epidemiology and Genetics of Schizophrenia. Amsterdam.Elsevier, 1988, 437 - 462.
  • 2Ganguli R, Yang Z, Shurin G, et al. Serum interlukin - 6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Research. 1994, 51, 1 - 10.
  • 3Mcallister CGV, Kammen DP, Kelley ME.Relapse prediction in schizophrenia : from monoamines to cytokines. In: Ebert D, et al(Series Eds) .Advances in Biological Psychiatry, volume 18. In:Henneberg AE, Kaschka WP (Eds) . Immunological Alterations in Psychiatric Diseases. Basel. Karger, 1997, 44 - 49.
  • 4Hopkins S.I, Rothwell N.I. Cytokines and the nervous system I:Expression and regulation.Trends in Neuroscience. 1995, 18, 83- 88.
  • 5Mehler MF, Kessler JA. Hematolymphopoetic and inflammatory cytokines in neural development. Trends in Neurescience, 1997, 20,357 - 365.
  • 6Merrill JE. Tumor necrosis factor alpha, interleukin 1 and related cytokines in brain development: Normal and pathological. Developmental of Neuroscience, 1992, 14, 1-10.
  • 7Vitkovic L, Bockaert J, Jacque C. "Inflammatory" cytokines:Neuromodulators in normal brain? Journal of Neurochemistry.2000, 74, 457-471.
  • 8Gilmore JH, Jarskog LF. Exposure to infection and brain development: Cytokines in the pathogenesis of schizophrenia. Schizophrenia Research, 1997, 24, 365-367.
  • 9Bothwell NJ, Hopkins SJ. Cytokines and the nervous system Ⅱ:Action and nechanisms of action.trends in Neuroscienee, 1995,18, 130- 136.
  • 10Loddick SA. Rothwel NJ. Mechanisms of tumor necrosis factor alpha action on neurodegeneration: interaction with insulin - like growth factor - 1. Proceeding of the National Academy of Sciences of the United States of America, 1999, 96, 9449 - 9451.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部